Enveda Raises $311 Million in Series E Round
AI-driven natural-medicine biotech Enveda has raised $311 million in a Series E round, one of the larger late-stage biotech financings of the year.
Topic
Series E
Topic
Series E
Rightway Raises $155M Series E Led by Francisco Partners
Rightway landed $155M in Series E funding from Francisco Partners, Thrive Capital and Khosla Ventures, while HIFI added $37M and…
Snorkel AI Triples Valuation to $3.5B on AI Data Demand
Snorkel AI raised $350 million at a $3.5 billion valuation as its annualized revenue run rate hit $375 million, an eighteenfold j…
Enveda Closes $311M Series E to Fuel Ambitions
Enveda has closed a $311 million Series E round, one of the year's larger biotech financings, to fund its stated ambition of beco…
Temporal's $550M Round Tops a Week of Smaller Checks
Temporal Technologies raised $550M at a $12.55B valuation to lead the week's biggest U.S. startup rounds, with Impulse Space and…
Enveda Doubles Valuation to $2B in $311M Series E Round
AI drug discovery startup Enveda raised $311M at a $2B valuation, double its worth from a year ago, to push nature-derived drug c…